Abstract
With the advent of tyrosine kinase inhibitors (TKIs), the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) has e......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
